Mauna Kea Technologies

Mauna Kea Technologies is a global medical device company that provides specialized equipment, supplies, and services to various federal agencies, including the Department of Veterans Affairs (VA), National Institutes of Health (NIH), and Defense Health Agency (DHA). The company's primary offering to the federal government is its Cellvizio platform, a real-time in vivo cellular imaging system used in clinical care and research programs. Mauna Kea Technologies holds a General Services Administration (GSA) Schedule 65-II-A contract for Medical Equipment and Supplies, which has a potential value of $4.5 million over five years. This contract vehicle enables efficient procurement of the company's products and services by federal healthcare organizations to support their specialized missions.

Through its federal contract awards, Mauna Kea Technologies has provided a range of goods and services to government agencies. These include the delivery of Cellvizio 100 Series laser medical devices, flexible probes, and cellular imaging platforms to VA healthcare systems and NIH research facilities. The company also offers preventive maintenance and repair services for its Cellvizio systems, with multi-year service contracts awarded by the VA and DHA. Additionally, Mauna Kea Technologies has supplied surgical supplies to the NIH Clinical Center and provided project management and research support for pulmonary equipment to the VA. The majority of these awards have been issued as firm-fixed-price purchase orders or delivery orders against the company's GSA Schedule, with no set-aside designations. Funding agencies have primarily been various VA healthcare networks, NIH institutes such as the National Heart, Lung, and Blood Institute and the National Cancer Institute, and the Defense Health Agency. The contract awards demonstrate Mauna Kea Technologies' ongoing support of federal healthcare and research initiatives through the provision of advanced medical imaging technology and associated services.